Phoniatric studies in myasthenia gravis patients [Phoniatrische untersuchungen an patienten mit myasthenia gravis]

被引:0
作者
Tóth L.
Pap U.
Diószeghy P.
Sziklai I.
机构
[1] HNO-Klinik (Direktor: Prof. Dr. I. Sziklai),
[2] Universität Debrecen,undefined
[3] Ungarn,undefined
[4] Neurologie-Klinik (Direktor: Prof. Dr. L. Csiba),undefined
[5] Universität Debrecen,undefined
[6] Ungarn,undefined
关键词
Myasthenia gravis; Phoniatrics; Voice profile;
D O I
10.1007/s001060050479
中图分类号
学科分类号
摘要
The authors have for the first time evaluated the basic parameters of the voice using computed voice analysis in patients with myasthenia gravis (MG). The aim of the study was to introduce an objective method suitable for the assessment of dysphonic symptoms, which predominate in bulbar, oculobulbar and generalized MG. Voice profile studies included the evaluation of the singing voice range, voice dynamics, maximum phonation time, and mean fundamental frequency and intensity, during speech. The characteristic of the stroboscopic picture was also determine. Investigations were carried out before and after the intake of Mestinon, a reversible cholinesterase inhibitor, and healthy subjects were used as a control group. In MG, the voice range and dynamics are badly impaired, maximum phonation time is shortened, the mean fundamental frequency during speech is increased, while the intensity is decreased. Mestinon resulted in an improvement in all these parameters, however, they were still impaired in comparison to the control subjects. Most changes were found to be statistically significant. The authors emphasize the role of the otolaryngologist and objective phoniatric methods in the evaluation of MG and other myasthenia-like neurological diseases. The use of these methods for the assessment of phoniatric symptoms in neurological diseases is highly recommended.
引用
收藏
页码:981 / 985
页数:4
相关论文
共 50 条
  • [31] Tongue force in patients with myasthenia gravis
    Weijnen, FG
    Kuks, JBM
    van der Bilt, A
    van der Glas, HW
    Wassenberg, MWM
    Bosman, F
    ACTA NEUROLOGICA SCANDINAVICA, 2000, 102 (05): : 303 - 308
  • [32] Psychosocial aspects in patients with myasthenia gravis
    Wolfgang Köhler
    Journal of Neurology, 2007, 254 : II90 - II92
  • [33] Myasthenia gravis: Study of 153 patients
    Da Cunha, FMB
    ARQUIVOS DE NEURO-PSIQUIATRIA, 1998, 56 (3A) : 512 - 513
  • [34] Treatment for diplopia in patients with myasthenia gravis
    Kyung-Ah Park
    Sei Yeul Oh
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2013, 251 : 895 - 901
  • [35] Treatment for diplopia in patients with myasthenia gravis
    Park, Kyung-Ah
    Oh, Sei Yeul
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (03) : 895 - 901
  • [36] Outcome of thymectomy in patients with Myasthenia Gravis
    Al-Mahdawi, AM
    Al-Talib, NM
    SAUDI MEDICAL JOURNAL, 2002, 23 (01) : 39 - 43
  • [37] Demyelinating disease in patients with myasthenia gravis
    Bichuetti, Denis Bernardi
    de Barros, Tatiane Martins
    Oliveira, Enedina Maria Lobato
    Annes, Marcelo
    Gabbai, Alberto Alain
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2008, 66 (01) : 5 - 7
  • [38] Management of Myasthenia Gravis
    Venkataramaiah, Sudhir
    Kamath, Sriganesh
    JOURNAL OF NEUROANAESTHESIOLOGY AND CRITICAL CARE, 2019, 6 (01) : 153 - 159
  • [39] Autoimmune myasthenia gravis
    Gilhus, Nils Erik
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (03) : 351 - 358
  • [40] Myasthenia gravis and thymoma
    De Assis, JL
    Zambon, AA
    Souza, PS
    Marchiori, PE
    ARQUIVOS DE NEURO-PSIQUIATRIA, 1999, 57 (01) : 6 - 13